Directed differentiation of hematopoietic cells from human pluripotent stem cells

Speakers
  • Research Associate, Center of Regenerative Medicine in Barcelona
    Biography
      Dr. Giorgetti holds a Bachelor of Biology (1998) and PhD in Molecular Medicine from the University of Milan, Italy. She has a long-standing interest in hematopoietic stem cells, which started in her PhD thesis. She continued her studies in Dr. Rafii´s Lab at the Weill Cornell Medical College in New York. In 2008 she joined Center of Regenerative Medicine of Barcelona (CMRB). Her work contributed to the molecular understanding of nuclear reprogramming (Cell Stem Cell 2009; Nature Protocols 2010; Nature 2011, Stem Cells 2011, PNAS 2012, Nature Commun 2013). In 2012, she joined Inbiomed as Head of the Laboratory of Hematopoiesis and Blood Disorders. In 2013, she relocated to the Josep Carreras Leukaemia Research Institute where she contributed to develop new strategies for the in vitro generation of blood cells (Stem Cell Reports 2016; Exp Hematol 2017; Stem Cells 2017). Recently she relocated to the CMR[B] where she has just established herself as Team Leader.

    Abstract:

    The continuous generation of blood cells throughout life relies on the existence of hematopoietic stem cells (HSC) generated during embryogenesis. Given the importance of HSC transplantation in cell-based therapeutic approaches, considerable efforts have been made toward understanding the developmental origins of embryonic HSC. Adult-type HSC are first generated in the aorta-gonad-mesonephros (AGM) region between days 27 and 40 of human embryonic development. It is relatively well accepted that the HSC emerge in the AGM through a hemogenic endothelium, but the direct precursor of this cell type remains to be clearly identified. The current picture of human hematopoietic development is largely extrapolated from animal models (mouse and zebrafish), as comparable studies on the human embryo are not possible. Human pluripotent stem cells (hPSCs) offer unprecedented opportunity to complement this knowledge, assuming that differentiation in the culture dish can recapitulate the dynamic and complexity of hematopoietic development in vivo. Here we summarize the recent advances made to understand the origins of hematopoietic stem cells in the early embryo and we discuss in detail latest protocols to obtain HSC from hPSCs.


    Show Resources
    You May Also Like
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    Loading Comments...
    Show Resources